Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Current Trends in Antibody Drug Conjugates

Current Trends in Antibody Drug Conjugates

Date: Monday, 2 March 2015 - Tuesday, 3 March 2015
Location: Bangalore, India

Keynote Speakers

Dimiter Dimitrov

Dimiter Dimitrov
Head/Senior Investigator, National Institutes of Health

Palani Palaniappan

Palani Palaniappan
Vice President & Head, Takeda Pharmaceuticals International Co.

Alain Bernard

Alain Bernard
Vice President, UCB Pharma SA


SELECTBIO brings to you its inaugural International conference on ADC Development & Manufacture "Current Trends in Antibody Drug Conjugates" on March 2-3, 2015 in Sheraton Bangalore Hotel at Brigade Gateway, Bangalore.

An innovative therapeutic application which combines the distinctive properties of monoclonal antibodies (mAbs) with the potent cytotoxic effect of small drug molecules is Antibody-drug conjugates or ADCs. This conference will be covering the different aspects of ADC development and manufacture, right from the introduction to regulatory aspects thereby ensuring comprehensive understanding of the subject. In addition this event will provide an excellent platform for knowledge sharing, collaborative research and networking with the scientists in the field of Antibody Engineering, Antibody drug conjugates, biopharmaceuticals and Cancer research.

This event is co-located with our International Conference on Cell Culture and Cell based assays i.e. CellTech India 2015. Running alongside the conferences will be an exhibition covering the latest advancements in the instrumentation for antibody and cell technologies related research and development.

International Advisory Board Members

Dr. Franck Pavan, Business Development Manager, Pierre Fabre, France
Dr. Ram Upadhayaya, Head- Medicinal Chemistry, Bioimics AB, Sweden
Dr. Satish Singh, Research Fellow and Group Leader, Pfizer, USA
Dr. Vijay Upreti, Principal Scientist, Clinical Pharmacology, Modeling & Simulation , Amgen, USA
Dr. Klaus Krauser, Executive Director- Safety Assessment, Novartis, Biotherapeutics Development Unit,USA
Dr. Jagath Reddy Junutula, Vice President-Antibody Discovery & Development, Cellerant Therapeutics, Inc., USA
Dr. Andreas Pahl, Chief Scientific Officer & Executive Vice President, Heidelberg Pharma, Germany
Dr. Janet Wolfe, President and Founder, Wolfe Laboratories, USA
Dr. Anil Wagh, Scientist, Bristol-Myers Squibb, USA

Note: For details of the conference package, please contact Ms. Sakshi,; 07696125050

Agenda Topics

  • ADC Development - Issues and Challanges
  • Bioanalytical & Pre-Clinical Development Strategies for ADCs
  • Cancer Antibody Therapeutics
  • Manufacture and Production Strategies for ADC
  • Novel Conjugation Technologies, Payload & Linkers
  • Strategies and Approaches for Development of Specific and Targeted ADCs

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Confirmed Speakers to date

Sanghamitra Bhattacharjee, Senior Scientist, Theramyt Novobiologics Pvt. Ltd
Tapas Das, Scientific Officer, Bhabha Atomic Research Centre
Dimiter Dimitrov, Head/Senior Investigator, National Institutes of Health
Ajay Kumar Gupta, Director & Head, Confederation of Indian Industry
Rajkumar Halder, Scientist E, Translational Health Science and Technology Institute
Preeti Nigam Joshi, INSPIRE Faculty, National Chemical Laboratory
Anjali Karande, Professor, Indian Institute of Science
Madan Katragadda, Senior Principal Scientist, Pfizer
G Praveen Kumar, Professor & Principal, Sahasra Institute of Pharmaceutical Sciences
Palani Palaniappan, Vice President & Head, Takeda Pharmaceuticals International Co.
Jeremy Parker, Project Leader, AstraZeneca
Priyaranjan Pattanaik, Associate Research Director, Syngene International Ltd
Tulsidas Shrivastav, Professor, National Institute of Health & Family Welfare
Mark Wright, Site Lead, Piramal Healthcare UK Ltd

Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2015-03-02 00:00:002015-03-03 00:00:00Europe/LondonCurrent Trends in Antibody Drug ConjugatesCurrent Trends in Antibody Drug Conjugates in Bangalore, IndiaBangalore,